BPC157

BPC157.com (slug: bpc157) is a U.S.-based research compound supplier with over 54 active listings on Peptides.SO, operating with a catalog that extends well beyond the brand's flagship namesake compound into GLP-1 receptor agonist research agents, SARMs, anti-aging compounds, and growth hormone-axis peptides. While BPC-157 remains an editorial anchor for the brand, the company has expanded into a multi-category research compound supplier serving investigators across metabolic biology, tissue repair, angiogenesis, and body composition research.

BPC-157 (Body Protection Compound-157) is the company's namesake and a central catalog entry. BPC-157 is a 15-amino acid synthetic peptide derived from a naturally occurring protein in gastric juice, extensively studied in gastrointestinal mucosal healing, tendon and ligament repair, angiogenesis promotion, anti-inflammatory signaling, and systemic tissue protection research. TB-500 (Thymosin Beta-4), often paired with BPC-157 in combination formulations, is studied for wound healing, actin-binding properties, cardiac tissue repair, and anti-inflammatory effects. BPC-157/TB-500 blends are available for multi-compound tissue repair research designs.

The GLP-1 research compound lineup includes GLP-3 (Retatrutide) and GL/P2/TZ (Tirzepatide), providing coverage for both dual- and triple-receptor GLP agonist research. Tirzepatide acts at both GLP-1R and GIPR receptors and has been studied for its distinct metabolic and adipose tissue biology compared to GLP-1 monotherapy. Retatrutide's additional glucagon receptor activity adds a third dimension to receptor pharmacology research.

BPC157.com's catalog beyond its namesake compound includes verified per-mg pricing on GHRP-6 at $10.00/mg (5mg) and Thymosin Alpha-1 at $18.00/mg (5mg) — the latter priced above the median for this compound relative to other suppliers surveyed in this batch, reflecting a smaller-vial-size premium rather than a quality differential.

The SARM segment is a significant catalog component. MK-677 (Ibutamoren), a non-peptide ghrelin receptor agonist studied for its GH-secretagogue properties, is a high-listing compound. LGD-4033 (Ligandrol), YK-11, RAD-140, MK-2866 (Ostarine), and MK-677 in multiple formats provide coverage for selective androgen receptor modulator pharmacology research. FST-344 (Follistatin-344), studied for its myostatin inhibition and skeletal muscle growth research applications, bridges peptide and SARM research categories.

Anti-aging research compounds include NAD+, GDF-8 (myostatin), and Epitalon. IGF-1 LR3 and PEG-MGF extend the growth factor research segment. All BPC157.com products are sold for laboratory and in-vitro research purposes only and are not intended for human or veterinary use.